Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)
- 18 February 2005
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 28 (1) , 21-27
- https://doi.org/10.1111/j.1365-2885.2004.00619.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and RifapentineAmerican Journal of Respiratory and Critical Care Medicine, 2003
- EPIDEMIOLOGY AND DIAGNOSIS OF ELEPHAS MAXIMUS)Journal of Zoo and Wildlife Medicine, 2001
- Tuberculosis in elephants in North AmericaZoo Biology, 2000
- Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamideAntimicrobial Agents and Chemotherapy, 1997
- The Value of In Vitro Drug Activity and Pharmacokinetics in Predicting the Effectiveness of Antimycobacterial Therapy: A Critical ReviewThe Lancet Healthy Longevity, 1997
- Elephants pack their trunks and leave the circusThe Lancet, 1997
- USING THERAPEUTIC DRUG MONITORING TO DOSE THE ANTIMYCOBACTERIAL DRUGSClinics in Chest Medicine, 1997
- Isoniazid Therapy in an Asiatic Elephant (Elephas maximus)The Journal of Zoo Animal Medicine, 1983
- Bioavailability of Three Isoniazid FormulationsJournal of Pharmaceutical Sciences, 1977
- Tuberculosis in a domesticated Asiatic elephant Elephas maximusPublished by Wiley ,1973